New Webinar: Demonstrating the Short and Long-Term Value of Gene and Cellular Therapies

Join us on December 11th for a unique one-hour video webinar, featuring some of the top gene and cell therapy leaders across Precision: “Demonstrating the Short and Long Term Value of Gene and Cellular Therapies”

Larry Blandford, Executive Vice President, will moderate a live panel discussion, tackling the evergreen challenge of how to demonstrate the short and long term value of a therapy when clinical data is lacking. The panel will include a variety of stakeholder perspectives, from payers to IDNs to economists. Jeremy Schafer, Senior Vice President and Head of the Access Experience Team, will share his thoughts, leveraging his payer experience at one of the top 5 largest PBMs. Avi Mamidi, title, will share thoughts from his work as a leader at a large IDN and the impact on HCPs and patients. Rebecca Dean, Senior Research Scientist on the HEOR team, and David Carr, Senior Engagement Director on the Global Pricing and Market Access Team will share their thoughts from a research and economist perspective from US and UK respectively.

Click the link to register today! 

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.